X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4744) 4744
Publication (453) 453
Book Chapter (27) 27
Book Review (23) 23
Conference Proceeding (4) 4
Magazine Article (2) 2
Book / eBook (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2440) 2440
index medicus (2342) 2342
pyrazines - pharmacology (2202) 2202
animals (1913) 1913
male (1436) 1436
bortezomib (1228) 1228
female (980) 980
pyrazines - therapeutic use (856) 856
boronic acids - pharmacology (726) 726
pharmacology & pharmacy (691) 691
rats (691) 691
oncology (677) 677
mice (673) 673
pyrazines - administration & dosage (646) 646
cell line, tumor (595) 595
middle aged (595) 595
apoptosis (582) 582
pyrazines - chemistry (551) 551
analysis (507) 507
biochemistry & molecular biology (503) 503
cancer (502) 502
apoptosis - drug effects (492) 492
adult (491) 491
antineoplastic agents - pharmacology (484) 484
pyrazines (454) 454
dose-response relationship, drug (441) 441
aged (389) 389
hematology (389) 389
sitagliptin phosphate (379) 379
multiple myeloma (358) 358
pyrazine (357) 357
research (355) 355
boronic acids - therapeutic use (347) 347
multiple myeloma - drug therapy (323) 323
chemistry, medicinal (320) 320
expression (292) 292
proteasome inhibitors (292) 292
endocrinology & metabolism (279) 279
activation (278) 278
boronic acids - administration & dosage (277) 277
pyrazines - pharmacokinetics (276) 276
rats, sprague-dawley (270) 270
cell proliferation - drug effects (264) 264
pyrazines - adverse effects (263) 263
care and treatment (260) 260
treatment outcome (254) 254
article (253) 253
proteins (253) 253
pyrazines - metabolism (249) 249
diabetes mellitus, type 2 - drug therapy (246) 246
antineoplastic agents - therapeutic use (245) 245
food science & technology (245) 245
chemistry, organic (243) 243
structure-activity relationship (239) 239
cell biology (233) 233
multiple-myeloma (227) 227
pyrazines - chemical synthesis (222) 222
cells (220) 220
drug synergism (215) 215
in vitro techniques (208) 208
drug therapy (207) 207
time factors (205) 205
protease inhibitors - pharmacology (203) 203
inhibition (202) 202
kinetics (201) 201
cell survival - drug effects (199) 199
health aspects (199) 199
molecular structure (198) 198
therapy (196) 196
chemotherapy (194) 194
nf-kappa-b (193) 193
sitagliptin (193) 193
triazoles - therapeutic use (193) 193
cells, cultured (189) 189
in-vitro (184) 184
medicine & public health (184) 184
tetramethylpyrazine (184) 184
amiloride - pharmacology (182) 182
glucose (180) 180
disease models, animal (179) 179
research article (179) 179
physiological aspects (176) 176
hydrogen-ion concentration (174) 174
type 2 diabetes (172) 172
cell line (168) 168
diabetes (162) 162
drug therapy, combination (162) 162
antineoplastic combined chemotherapy protocols - therapeutic use (158) 158
pharmacokinetics (157) 157
proteasome endopeptidase complex - metabolism (157) 157
multiple myeloma - pathology (154) 154
phosphorylation (154) 154
derivatives (153) 153
in-vivo (153) 153
signal transduction - drug effects (153) 153
hypoglycemic agents - therapeutic use (152) 152
triazoles - pharmacology (151) 151
medicine (148) 148
chemistry (146) 146
chemistry, multidisciplinary (140) 140
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4638) 4638
Chinese (97) 97
German (8) 8
Russian (8) 8
French (6) 6
Czech (3) 3
Japanese (3) 3
Danish (1) 1
Dutch (1) 1
Korean (1) 1
Polish (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS Neglected Tropical Diseases, ISSN 1935-2727, 02/2017, Volume 11, Issue 2, p. e0005389
Journal Article
The Journal of Physiology, ISSN 0022-3751, 06/2013, Volume 591, Issue 11, pp. 2897 - 2909
Journal Article
Journal of the Science of Food and Agriculture, ISSN 0022-5142, 10/2008, Volume 88, Issue 13, pp. 2288 - 2297
Journal Article
Journal Article
15.